877-202-0205     support@chemchart.com     @chemchart
        
Sign In    Register
   Reset Filters

Polycyclic organic compounds, Cyclopropanes, Antineoplastic and immunomodulating drugs, Organohalides

Categories

Antineoplastic drugs (1)
Cyclic compounds (1)
Cycloalkanes (1)
Experimental cancer drugs (1)
Halides (1)
Organofluorides (1)
Pharmaceuticals (1)
Piperazines (1)
Six-membered rings (1)
Tetracyclic compounds (1)
Three-membered rings (1)

Suppliers

Matrix Scientific (1)

Zosuquidar Trihydrochloride (167465-36-3)  
Zosuquidar (also LY-335979) is an experimental antineoplastic drug. In 2010, it was announced that a phase III trial for the treatment of acute myeloid leukemia (AML) and myelodysplastic syndrome did not meet its primary endpoint and Eli Lilly discontinued its development. Zosquidir inhibits P-glycoproteins.
Related searches
Polycyclic organic compounds
Cyclopropanes
Antineoplastic and immunomodulating drugs
Organohalides